Phuah Chia-Ling, Raffeld Miriam R, Ayres Alison M, Viswanathan Anand, Greenberg Steven M, Biffi Alessandro, Rosand Jonathan, Anderson Christopher D
From the Division of Neurocritical Care and Emergency Neurology (C.-L.P., J.R., C.D.A.), Center for Human Genetic Research (C.-L.P., M.R.R., A.B., J.R., C.D.A.), The J. Philip Kistler Stroke Research Center (A.M.A., A.V., S.M.G., J.R., C.D.A.), and Hemorrhagic Stroke Research Group (A.M.A., A.V., S.M.G., A.B., J.R., C.D.A.), Massachusetts General Hospital, Boston; and Program in Medical and Population Genetics (C.-L.P., A.B., J.R., C.D.A.), Broad Institute, Cambridge, MA.
Neurology. 2016 May 31;86(22):2034-41. doi: 10.1212/WNL.0000000000002716. Epub 2016 Apr 29.
We aimed to describe the temporal variation in circulating lipid levels among patients with intracerebral hemorrhage (ICH) and investigate their association with ICH risk.
This was a single-center, retrospective, longitudinal, case-control analysis using cases drawn from an ongoing cohort study of primary ICH and controls drawn from a hospital-based clinical data registry. Piecewise linear mixed-effect random coefficient models were used to determine the significance of changes in serum lipid trends on ICH risk.
Two hundred twelve ICH cases and 301 control individuals were analyzed. Overall trends in serum total cholesterol (TC) and low-density lipoprotein (LDL) levels differed between ICH cases and non-ICH controls (p = 0.00001 and p = 0.0092, respectively). Patients with ICH experience accelerated decline in serum TC and LDL levels during 6 months immediately preceding ICH, compared with levels between 6 and 24 months pre-ICH (TC: -29.25 mg/dL, p = 0.001; LDL: -21.48 mg/dL, p = 0.0038), which was not observed in non-ICH controls. Subgroup analysis confirmed that this phenomenon cannot be attributed to statin or alcohol exposure. Serum triglycerides and high-density lipoprotein trends did not differ between groups.
Longitudinal lipid levels differ between ICH cases and non-ICH controls, most notably for a decline in serum TC and LDL levels within 6 months preceding primary ICH, independent of statin or alcohol use. These changes in serum TC and LDL trends suggest a biological pathway that precipitates ICH occurrence. Further studies are needed to replicate these results and characterize rate of change in serum lipids as a potential biomarker of impending acute cerebral injury.
我们旨在描述脑出血(ICH)患者循环脂质水平的时间变化,并研究其与ICH风险的关联。
这是一项单中心、回顾性、纵向病例对照分析,病例来自正在进行的原发性ICH队列研究,对照来自基于医院的临床数据登记处。采用分段线性混合效应随机系数模型来确定血清脂质趋势变化对ICH风险的显著性。
分析了212例ICH病例和301例对照个体。ICH病例和非ICH对照之间血清总胆固醇(TC)和低密度脂蛋白(LDL)水平的总体趋势不同(分别为p = 0.00001和p = 0.0092)。与ICH前6至24个月的水平相比,ICH患者在ICH前6个月内血清TC和LDL水平加速下降(TC:-29.25mg/dL,p = 0.001;LDL:-21.48mg/dL,p = 0.0038),非ICH对照中未观察到这种情况。亚组分析证实,这种现象不能归因于他汀类药物或酒精暴露。两组之间血清甘油三酯和高密度脂蛋白趋势没有差异。
ICH病例和非ICH对照之间的纵向脂质水平不同,最显著的是原发性ICH前6个月内血清TC和LDL水平下降,与他汀类药物或酒精使用无关。血清TC和LDL趋势的这些变化提示了一条促使ICH发生的生物学途径。需要进一步研究来重复这些结果,并将血清脂质变化率表征为即将发生急性脑损伤的潜在生物标志物。